Exosens SA

Exosens SA

56.90
EUR
-1.00
(-1.73%)
2.90BMarket Cap
Feb 22Next Earn
Exosens SA
GETTEX:H8Y
(Gettex)

Recent

price

56.90

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
2025
TTM
EUR
4.93
5.47
6.61
9.6
9.22
7.56
- -
Revenue per Share
-0.52
-4.9
0.37
0.61
0.84
0.61
- -
Basic EPS, GAAP
1.45
1.4
0.85
0.64
1.95
2.12
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
0.1
- -
Dividend per Share
1.91
3.39
3.6
4.02
8.13
8.79
8.86
Book Value per Share
-6.61
-2.44
-2.71
-3.4
0.36
-0.27
0.39
Tangible Book Value per Share
30
30
30
30
51
51
51
Basic Weighted Avg Shares
150
166
201
292
468
383
- -
Sales/Revenue/Turnover
20.44
19.48
16.41
18.72
21.83
21.02
- -
Operating Margin (%)
8
11
19
28
35
40
- -
Depreciation Expense
-16
-149
11
18
43
31
- -
Net Income, GAAP
- -
- -
34.45
9.06
20.41
25.33
- -
Effective Tax Rate (%)
-10.56
-89.65
5.59
6.31
9.12
8.01
- -
Profit Margin (%)
60
59
72
83
207
167
176
Working Capital
429
204
243
304
8
14
260
LT Debt
97
172
183
204
413
446
451
Total Equity
- -
- -
5.06
9.72
16.75
13.61
- -
Return on Invested Capital (%)
- -
- -
5.21
9.05
9.09
6.93
- -
Return on Capital (%)
- -
-110.67
6.31
9.51
13.85
7.15
- -
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Jun'24
Dec'25
Jun'26
ST Debt
2
3
5
LT Borrowings
247
- -
247
LT Finance Leases
8
14
13
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
51
51
51
Market Capitalization
1,086
2,418
2,899

Working Capital

EUR

•

in mil. unless spec.
Jun'24
Dec'25
Jun'26
Total Current Assets
316
280
306
Cash, Cash Equivalents & STI
123
102
69
Accounts Receivable, Net
60
73
68
Inventories
95
105
123
Total Current Liabilities
112
114
130
Payables & Accruals
- -
- -
- -
ST Debt
2
3
5
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
41.06%
8%
Free Cash Flow
- -
69.36%
8.7%
Net Income, GAAP
- -
180.33%
-28.1%
Sales/Revenue/Turnover
- -
23.88%
-18.11%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
468
2025
- -
- -
383
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.84
2025
- -
- -
0.61
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
0.1
2026
- -
- -
- -
Business
Exosens Technologies SA (EXENS.PA) is a leading provider of advanced optoelectronic solutions and image sensors for industrial, medical, scientific, and defense applications. The company develops and manufactures high-performance sensors, including CMOS image sensors, SWIR detectors, and X-ray imaging solutions; electron microscopy components such as cameras and detectors; and specialized systems for night vision, LiDAR, and hyperspectral imaging under brands like Lynred for infrared technologies and Teledyne e2v for scientific imaging. Exosens serves target markets including aerospace and defense, medical diagnostics, semiconductor inspection, and research institutions, with operations spanning Europe, North America, and Asia. Founded in 2023 through the acquisition and rebranding of Teledyne e2v by the European consortium Wisag, which includes investment from shareholder Partech, Exosens is headquartered in Paris, France, with key facilities in Grenoble, France; Chelmsford, UK; and global sites in the United States and Asia. In recent developments, Exosens completed its initial public offering on Euronext Paris in October 2024, raising approximately EUR 324 million to fuel expansion in AI-driven imaging and strategic growth initiatives; announced a strategic partnership with STMicroelectronics in 2025 to co-develop next-generation SPAD-based LiDAR sensors for automotive and robotics; and launched the new Emerald SWIR sensor platform in mid-2025, enhancing compact hyperspectral imaging for industrial sorting and defense reconnaissance.